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Abstract 25 
Copaiba is the oleoresin (OR) obtained from Copaifera (Fabaceae), a  neotropical tree which grows 26 
in Amazon regions. The balsam, constituted by an essential oil and a resinous fraction is used as 27 
folkloristic remedy in the treatment of several inflammatory diseases and for its antioxidant and 28 
antibacterial properties. Aim of this work was (a) to carry out a characterization by GC-MS of the 29 
volatile and nonvolatile constituents of Copaifera  langsdorffii Desf. oleoresin (OR); (b) to 30 
investigate the mechanism of its anti-inflammatory activity; (c) to evaluate its antipsoriatic effect 31 
after oral intake/topical application. The volatile fraction (yield: 22.51% w/w) shows: -32 
bergamotene (48.38%), -himachalene (11.17%), -selinene (5.00%) and -caryophyllene (5.47%). 33 
The OR residue (77,49% w/w), after derivatization, showed as main constituents the following 34 
compounds: copalic,  abietic, daniellic, lambertinic, labd-7-en-15-oic, pimaric, isopimaric acids and 35 
kaur16-en18-oic acid.  36 
Preincubation of LPS-stimulated human THP-1 monocytes with increasing concentrations of the 37 
OR purified fraction (OR-PF), containing diterpene acids, diterpenes and sesquiterpenes, reduced 38 
the release of pro-inflammatory cytokines (IL-1, IL-6, TNF) in a dose-range of 0.1-10 M. 39 
In addition, in cell culture system of human THP-1 monocytes, 1M OR-PF counteracts LPS-40 
driven NF-kB nuclear translocation. 41 
In a preliminary clinical trial three patients affected by chronic psoriasis, treated with oral intake or 42 
topical application of the OR, exhibited a significant improvement of the typical signs of this 43 
disease, i.e. erythema, skin thickness, and scaliness. 44 
In conclusion, the results of this work, beside an extensive analytical characterization of the OR 45 
chemical composition, provide strong evidences that its anti-inflammatory activity is related to the 46 
inhibition  of  the NF-B nuclear translocation, and consequently of proinflammatory cytokines 47 
secretion. 48 
 49 
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1. Introduction 54 
 55 
Copaiba is the oleoresin (OR) obtained from Copaifera (Fabaceae), a family of neotropical trees  56 
which grows throughout the Amazon regions. Copaiba balsam is obtained from more than twenty 57 
arboreal species, among which the most studied are C. officinalis, C. reticulata, C. duckei, C. 58 
multijuga, C. langsdorffii, C. hayn, C. epunctata, C. guyanensis and C. panamensis.  59 
The balsam, constituted by an essential oil and a xyloglucanic resinous fraction (Stupp et al., 2008), 60 
accumulates in cavities within the tree trunk, and it is used in traditional medicine in the treatment 61 
of several inflammatory diseases involving the respiratory airways (such as asthma, sore throat, 62 
bronchitis), the genital-urinary apparatus an the skin diseases (healing of scurs skin ailments: 63 
wounds, eczema and herpes). 64 
It constitutes one of the most important renewable source of natural remedy for the populations of 65 
the amazon region. 66 
In United States it was an official drug reported in the U.S.P. from 1820 to 1910, and in 1940 was 67 
admitted in the National Formulary. In 1972 the OR has been approved as dietary supplement by 68 
the FDA, after assessment of its safety, and more recently in Italy as food supplement by the Italian 69 
Ministry of Health (http://www.salute.gov.it; 2011). 70 
Notwithstanding the clinical evidences that the OR from C. langsdorffii Desf. can ameliorate the 71 
outcome of inflammatory-mediated gastrointestinal, genital, urinary and pulmonary diseases 72 
(Santos et al., 2008), few studies have been focused on its  molecular mechanisms through which 73 
this OR exerts its action. This is due to the poor analytical background on its chemical constituents: 74 
while several informations are reported in literature about the composition of the essential oil 75 
(Veiga et al., 2001), few are those available (and some of them still in progress) relative to the 76 
profile of its nonvolatile components, such as dipertenes, diterpenoic acids and sesquiterpenes 77 
(Leandro et al., 2012; do Nascimento et al., 2012).  78 
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Hence, despite these recently published papers, the relationship between the C. langsdorffii Desf. 79 
OR chemical composition and its pharmacological activity remains undefined. In the light of this 80 
gap, and of the re-emerging interest for this popular and traditional remedy, aim of this study was: 81 
a) to perform an exhaustive study on the composition of its constituents; b) to isolate the most 82 
active fraction of the OR; c) to evaluate in an immunocompetent cell culture system, THP-1 human 83 
monocytes, their inhibitory activity on the LPS-stimulated secretion of the pro-inflammatory 84 
cytokines, and of the nuclear translocation of NF-B. 85 
Finally we have carried out a preliminary testing on the potential antipsoriatic activity of the OR in 86 
a restricted number of subjects affected by recalcitrant localized psoriasis. 87 
 88 
2. Materials and methods 89 
 90 
2.1 Copaiba oil  91 
The OR was collected from the trunks of C. langsdorffii Desf. trees, growing wild in the Amazon 92 
region in Northern Brazil during October 2011. Authentication of the species was carried out by the 93 
examination of its seeds, fruits and leaves by Prof. Gelsomina Fico, Department of Biology, Faculty 94 
of Pharmacy, University of Milan. Two voucher specimens were deposited in the herbarium of the  95 
Department of Biology of the same University. 96 
 97 
2.2 Chemicals 98 
Thiobarbituric acid, n-hexane, trolox, butanol, methanol, ethanol, gallic acid, ascorbic acid, 99 
Ethylenediaminetetraacetic acid sodium salt, trichloroacetic acid, hydrogen peroxide 30%, 100 
potassium hydroxide, gaseous hydrochloric acid, Bradford reagent, phenol, bovine serum albumin 101 
(BSA), abietic acid (AA) and lipopolysaccharide (LPS) were all from Sigma–Aldrich (Milan, Italy). 102 
1,1-diphenyl-2-picrylhydrazyl (DPPH), and Folin–Ciocalteau reagent were from Fluka (Buchs, 103 
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Switzerland). Glucose, FeCl3 were from Carlo Erba (Milan, Italy). Human IL-1β, IL-6 and TNF-α 104 
enzyme-linked immunosorbent assay (ELISA) kits were purchased from R&D Systems 105 
(Minneapolis, MN, USA).  106 
 107 
2.3 Physical parameters 108 
The physical constants were analyzed (20 ± 0.2°C) according to the standard methods of the 109 
Association Française de Normalisation (AFNOR). The refractive index of the essential oil (EO) 110 
was determined at 25 °C with an Abbe optical refractometer (Ivymen System). The optical activity 111 
of essential oil was measured in ethanol at 25 °C with a D7 optical polarimeter (Bellingham & 112 
Stanley Ltd., Tunbridge Wells, Kent U.K.) working at  589 nm. The density of the OR was 113 
determined gravimetrically as m/vol ratio (g/mL). The saponification and acidic indexes were 114 
determined according to the methods reported in the European Pharmacopeia 7
th
 edition. 115 
 116 
2.4 Free  sugar determination 117 
The analysis of free monosaccharide fraction was performed according to Dubois (Dubois et al., 118 
1956) and expressed as glucose equivalent/mgOR.  119 
 120 
2.5 Polysaccharide analysis 121 
The average molecular weight (MW) of the xyloglucan fraction was determined dissolving the 122 
matrix in ethanol, since its poor solubility in water. Detection was carried out in off line mode using 123 
a light scattering multiangle DAWN-DSP-F apparatus (Wyatt Technology model Corp., Santa 124 
Barbara, CA) equipped with a 5-mW He-Ne laser source (632.8 nm). The average MW was 125 
between 5x10
3
 -  1x10
4 
da. 126 
 127 
 128 
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2.6 Total reducing substances  129 
The total content of reducing substances was determined using two different methods: 130 
(a) Folin–Ciocalteau assay with minor modifications (Vinson and Bose, 2001), and expressing the 131 
results as mg of gallic acid equivalent (mgGAE/mg of samples). 132 
Briefly, 300 l of the OR properly diluted in ethanol (30 l/ml) were added to 2.7 mL of Folin–133 
Ciocalteau reagent previously diluted (1:10) with milliQ water. The mixture was vortexed for 2 134 
min, and the spectrophotometric absorbance was measured at 750 nm, after 20 min incubation at 135 
room temperature against a blank (reagents and ethanol). Gallic acid was used to calibrate the 136 
concentration as a function of absorbance. The gallic acid equivalent content (mgGAE /mLsamples ± 137 
SD) was calculated by comparison with a calibration curve plotted with a diluted stock solution (1 138 
mg/mL) of gallic acid in EtOH/H2O (1:1). The calibration line (y = 0.01162x + 0.04261) was linear 139 
(R
2
 = 0.9997) between 0.01 and 0.50 mg/mL. 140 
(b) Prussian blue method (Price and Butler, 1977), with minor modifications: 100 μL of ethanol 141 
containing different amounts of OR (from 1 to 50 μL) were added to a solution composed by 3 mL 142 
of 0.1 M FeCl3 in 0.1 N HCl and 3.0 mL of 8.0 mM of K3[Fe(CN)6] and vigorously vortexed. The 143 
absorbance was determined spectrophotometrically at λmax 720 nm, after 10 min incubation at room 144 
temperature. All analyses were done in triplicate. The results were expressed as mgGAE/mLEO ± S.D. 145 
The GAE was calculated as described above, and the calibration curve (y=0.03690x+0.06004) was 146 
linear (R
2
=0.9995) between 0.01 and 0.50 mg/mL. 147 
 148 
2.6.1 Free radical scavenging activity of C. langsdorffii Desf. OR 149 
The H/e
-
 transferring ability of the components of the OR in toto, of its resinous fraction, and of the 150 
essential oil were evaluated by the conventional DPPH assay. The extent of the DPPH radical  151 
quenching, expressed as: (a) RSC% according to the formula: RSC% = [(ACTR − AEO)/ACTR ] × 152 
100; (b) IC50 value was calculated as previously described (Beretta et al., 2011). 153 
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2.6.2 Scavenging effect of C. langsdorffii Desf. OR of hydroxyl radicals 154 
The hydroxyl radical scavenging activity was evaluated according to the conventional method  of 155 
Halliwell et al. (1987). The OR was diluted 1:1000 v/v with ethanol and 10-40 L, corresponding to 156 
10-40 nL of OR, added to the assay mixture under vigorous vortexing at 37°C for 1 hour. 157 
Measurements were carried out against a blank in which pure ethanol was added. 158 
 159 
2.6.3 Scavenging effect of the OR on hydrogen peroxide 160 
The ability of the OR to scavenge H2O2 was determined according to the method of Yen and Duh 161 
(1994) with minor modifications. A solution (2 mM) of H2O2 was prepared in phosphate-buffered 162 
saline (PBS) pH 7.41 at 20 °C. H2O2 concentration was determined spectrophotometrically at  230 163 
nm using a molar extinction coefficient for hydrogen peroxide of 81 M
-1
 cm
-l
 (Beers and Sizer, 164 
1952). Different amounts of OR (1, 5, 10, 15 μL) were dissolved in EtOH (1 mL): 10 μL of each 165 
solution (containing respectively 10, 50, 100, and 150 nL of OR) were added to 990 μL of 166 
H2O2/PBS mixture at 20 °C. The absorbance of H2O2 was determined spectrophotometrically at 230 167 
nm after 10 min of incubation (CARY 50, Varian) against a blank solution containing the OR 168 
dissolved in the same conditions and diluted in PBS without H2O2. All tests and analyses were run 169 
in three replicates and averaged. 170 
 171 
2.7 EO and resinous complex isolation 172 
The EO from C. langsdorffii Desf. was isolated by conventional steam distillation (10 g of OR; 173 
yield 22,50% w/w) and then submitted to GC-MS analysis for the characterization of its 174 
components. The OR resinous fraction was prepared from the same amount of OR, after 175 
evaporation of the EO under reduced pressure (2.8 mbar, 100 °C, chilling temperature -5 °C), until 176 
constant weight of the residue. 177 
 178 
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2.8 Sample derivatization 179 
The resinous complex was submitted to GC-MS analysis after derivatization. Briefly, 50 L of 180 
samples were treated with 450 L of MeOH saturated with gaseous HCl, and left to react for 1 hour 181 
at 40 °C. The mixture was then exhaustively extracted with 1 mL of n-hexane, and 1 l of the 182 
extract submitted to GC-MS analysis. This procedure allows to characterize the diterpenoic acids 183 
and derivatives, and the sesquiterpenes embedded into the polymeric matrix of the resinous 184 
complex, as well as the residual traces of paraffins, not eliminated during the evaporation of the 185 
essential oil. 186 
 187 
2.9  Isolation of the sesquiterpenes and of diterpenoic acids from the polymeric matrix 188 
The isolation of the purified fraction of the OR (OR-PF), containing diterpenes acids, diterpenes 189 
and sesquiterpenes was performed according to protocol shown in Scheme 1. 190 
 191 
2.10 GC-MS conditions 192 
The essential oil profile of Copaiba OR was performed by GC-MS analysis using a Bruker Scion 193 
SQ instrument (Bruker Daltonics, Macerata, Italy), equipped with a Factor Four capillary column 194 
(VF-5 ms, 30 m; 0.25 mm i.d., film thickness 0.25 m) coupled with a SQ (single quadrupole) 195 
detector. The oven temperature was initially set at 60 
°
C (hold time 3min), with a gradient from 60 196 
to 120 
°
C (3.0 °C/min, hold 1 min), from 120 to 280 
°
C (2 
°
C/min, hold 1 min), and from 280 to 300 197 
°
C (10 
°
C/min, hold 2 min); injector temperature 290 °C, hold 95 min. Column flow 1.00 mL/min. 198 
Carrier gas helium 5.5; ionization energy 70 eV; the split/splitless ratio was set to 1:30 after 45 s. 199 
Peaks were identified by matching their mass spectra with those of the commercial library NIST 200 
mass spectral database (vers. 2.0, 2011) and with those of commercial standards when necessary. 201 
The percentage composition of the constituents was obtained by normalization of the peak areas. 202 
 203 
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2.11 Biological activity: in vitro studies 204 
 205 
2.11.1 Cell culture 206 
Human THP-1 monocyte cell line was used (American Type Culture Collection, ATCC). Cells 207 
were routinely cultured as follows: they were diluted to 10
6 
cells/ml in RPMI 1640 containing 2 208 
mM L-glutamine, 0.1 mg/ml streptomycin, 100 IU/ml penicillin, 0.05 mM 2-mercaptoethanol, 209 
supplemented with 10% heated-inactivated fetal bovine serum (FBS; Gibco, Grand Island, NY) and 210 
cultured in 37°C in 5% CO2 incubator. For IL-1β, IL-6 and TNF-α release experiments, THP-1 cells 211 
were seeded in 24-well plates, while for Western blot analysis 4x10
6
 cells were cultured in 15 ml 212 
polypropylene tubes. Cells were incubated with or without LPS in the presence or absence of 213 
increasing concentrations of OR-PF (0.1-100 μM). THP-1 cell viability rate was assessed by trypan 214 
blue exclusion test. AA (abietic acid), at the dose of 4x10
-5
 M, was used as a positive control of OR-215 
PF (Kim 2010). Dimethyl sulphoxide and ethanol (0.1% final concentration) were used as vehicle 216 
controls. 217 
 218 
2.11.2 IL-1β, IL-6 and TNF-α ELISA 219 
The most effective dose of LPS was 1 μg/mL, in accordance with previous studies on THP-1 220 
(Corsini, 2011; Esafi-Benkhadir, 2012). Cells were pretreated or not for 1 h with OR-PF (0.1-100 221 
μM) and 4x10-5 M AA; then exposed to 1 μg/mL LPS for further 24 h. Culture medium was then 222 
removed, centrifuged for 10 min at 1.200 rpm at 4 °C and stored at -80 °C until measurement. The 223 
lowest limits of sensitivity were 3.9 pg/mL for human IL-1β; 0.70 pg/mL for human IL-6 and 0.5-224 
5.1 pg/mL for human TNF-α. The serum in the culture media did not interfere with the assay. 225 
Cytochine levels were normalized to the cell number. 226 
 227 
 228 
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2.11.3 Western blot analysis (WB)  229 
THP-1 cells were cultured in 15 ml polypropylene tubes at the density of 4x10
6
 cells. They were 230 
pretreated or not for 1 h with 1μM OR-PF then exposed to 1 μg/mL LPS for another 30 minutes. 231 
NE-PER nuclear and cytoplasmic extraction reagents (Thermo Scientific, Rockford, IL, USA) were 232 
used according to the manufacturer’s instructions to extract nuclear and cytoplasmic proteins. 233 
Protein concentrations were assessed by bicinchoninic acid assay (BCA) Thermo Scientific, 234 
Rockford, IL, USA. Proteins were denatured and fractionated on a 4-20% gradient gel by SDS-235 
PAGE then transferred electrophoretically to Hybond C-extra nitrocellulose membranes. Non-236 
specific binding sites were blocked by treating the membranes with Tris-buffered saline-Tween 237 
(TBS-T) containing 5% non-fat dried milk for 1 h at 22°C. 238 
To assess the presence of NF-B in nuclear and cytoplasmic fractions, membranes were incubated 239 
for 16 h at 4°C with a 1:100 dilution of anti-NF-B p65 polyclonal antibody (Santa Cruz 240 
Biotechnology, CA) and incubated for 1 h at 22 °C with a 1:4000 dilution of horseradish 241 
peroxidase-linked anti-rabbit IgG. To normalize total NF-B to nuclear and cytoplasmic fractions, 242 
membranes were immunoblotted with 1:1000 anti-histone H3 (Cell Signaling Technology, MA) 243 
and 1:2000 anti-tubulin (Sigma-Aldrich, St. Louis, MO), respectively. Membranes were then 244 
washed with TBS-T, immersed in the chemiluminescence detection solution. The luminescence was 245 
then quantified in a Chemidoc system and the bands were quantified by Image Lab (both from Bio-246 
Rad Laboratories, Milan, Italy). 247 
 248 
2.12 In vivo studies: antipsoriatic activity 249 
 250 
2.12.1 Oral intake 251 
Two patients (36 and 45 years old, woman and man respectively) with an 8 year history of chronic 252 
psoriasis from mild to moderate (grade 1 and 2 of the Psoriasis Area Scale Index, PASI scale: 0-253 
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none-, 1-slight-, 2-mild-, 3-moderate-, 4-severe; Feldman and Krueger, 2005), localized in man on 254 
the legs, and in the woman on the elbows, were considered. 255 
The patients, recalcitrant to topical treatment with conventional anti-psoriatic drugs (corticosteroids 256 
and vitamin D analogues) and not affected by considerable comorbidities, gave their informed 257 
consent to the oral treatment with the C. langsdorffii Desf. OR. 258 
Before the treatment, patients carried out an extensive therapeutic wash out (four weeks) and then 259 
started the intake of the OR, with an initial dose of one drop t.i.d. (ter in die), daily increasing the 260 
dose from one to seven drops t.i.d., equivalent to 1 mLOR/die. 261 
 262 
2.12.2 Topical treatment 263 
A 36 year-old-man affected by severe psoriasis localized at both the elbows, graded from 2 to 3 264 
according to the PASI scale, was treated on the left with an ointment containing 0.005% of 265 
calcipotriol, and on the right with an ointment constituted by 5% of C. langsdorffii Desf. OR 266 
dissolved in karitè shea butter, containing the 0.1% of tea tree oil as skin penetration enhancer. The 267 
treatment was carried out twice daily on symmetrical lesions for 6 weeks. The patient gave 268 
informed consent to the treatments. The effect was assessed by clinical visual examination of 269 
erythema, of scaling, and finger palpation of the lesions. 270 
 271 
2.13. Statistical analysis 272 
Statistical analyses were conducted with the R-commander GUI for R (v. 1.5–6) (Fox, 2005). 273 
Results are expressed as the mean (S.D.) of at least three independent experiments. Student's t-test 274 
was used; P-values <0.05 were considered significant. 275 
 276 
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3.1 Results and discussion 277 
The results relative to the organoleptic characteristics and to the physical-chemical descriptors of 278 
the OR and of the EO (22% w/w) are reported in Table 1. Color, odor, boiling point, refractive 279 
index, optical rotation, and specific gravity, match those already reported in literature (Remington 280 
and Wood, 1918: the US Dispensatory). All this data indicate the authenticity of the OR in toto and 281 
of its EO.  282 
The total free acids value of OR was 102.450 ± 5.044 (mgKOH/gOR), and the saponification index 283 
107.450 ± 2.040 (mgKOH/gOR): the overlapping of these two values indicates the presence of acids in 284 
free form only. From a stoichiometric calculation based on these data, and considering the MW of 285 
the two prototype diterpene acids (kaurenoic and copalic acids, C20H32O2, MW=304.24), we can 286 
estimate a content in acid fraction in the OR of 56,89 ± 1,22%. 287 
The free sugar content expressed as mg glucose/ mLOR was 0.69 ± 0.03 % (w/w). The low amount 288 
of free sugars indicates that these may be considered more as contaminants of the OR than as a 289 
hydrolytic products from its xyloglucan fraction. This last is known to be insensitive to acidic or 290 
basic hydrolysis and susceptible only in part to degradation by enzymatic treatment with cellulase 291 
and -galactosidase (Silva Tiné et al., 2003). The sticky structure of the hydrocolloid confirms its 292 
protective function inside and outside the trunk against wounds and attack of bacteria, insect and 293 
fungi. 294 
 295 
3.2 Antioxidant and antiradical activities 296 
 297 
3.2.1 Total reducing substances 298 
The total content of reducing substances determined by both the Folin-Ciocalteau and 299 
FeCl3/Fe(CN)6
- 
 in OR in toto were 0.318 ± 0.04 mgGAE/gOR and 0.212 ± 0.01 mgGAE/gOR, 300 
respectively. The content of reducing substances determined on the essential oil, and on the resinous 301 
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complex, gave a value below the limit of detection.  302 
The DPPH assay was first performed on the OR in toto (IC50 2.30 mg/mL), and then on its 303 
constitutive components, i.e. the essential oil (IC50 8.71 mg/mL) and on the xyloglucanic resin 304 
which contains entrapped diterpenes and diterpenoic acids (IC50 9.23 mg/mL). From these results, it 305 
is clear a synergistic effect of the components, commonly observed in several phytocomplexes 306 
containing H/e- tranferring structures (Beretta et al., 2011). 307 
 308 
3.2.2 
.
OH scavenging activity 309 
The 
.
OH scavenging activity evaluated according to Halliwell et al. (Hall, 1987) demonstrated a 310 
dose dependent  inhibition of the TBA-MDA chromogen of 35.54%,  56.39%, 70.31%, and 75.10% 311 
after addition of  10 nL, 20 nL, 30 nL, and 40 nL respectively of the OR suitably diluted in the 312 
minimal amount of ethanol , indicating that the balsam, at least in part, is able to quench the flux of 313 
highly reactive 
.
OH radicals generated by the Fe
3+
/H2O2/ascorbate redox system. The observed 314 
effect may be in part due also to the direct quenching activity of the OR towards H2O2. 315 
 316 
3.2.3 Effect on H2O2  317 
A dose dependent effect of the OR on H2O2 (2 mM) was observed: 10, 50, 100, and 150 nlOR/mL 318 
induce a progressive decrease in the absorbance at  230 nm of 2 mM H2O2  (from 1.98 mM to 0.30 319 
mM), to indicate that the components of OR are able to quench directly H2O2. 320 
Interestingly, 1 mL of EtOH containing 2 L of OR shows in the UV spectrum a sharp peak at 272 321 
nm typical of endocyclic conjugated dienes, which, when added with 2 L of concentrated H2O2 322 
(30% v/v), undergoes complete disappereance (Fig. 1). This behavior may suggest the presence in 323 
the OR of a set of -unsaturated diterpenic compounds. Not surprisingly the antiradical activity 324 
(DPPH assay) of the OR when saturated with H2O2, undergoes a dramatic drop. The IC50 value rises 325 
from 2.30 mg/mL to 13.52 mg/mL. These findings, although preliminary, indicate that in the 326 
Page 16 of 37
Ac
ce
pte
d M
an
us
cri
pt
15 
diterpene structure of the compounds the active groups responsible for the antiradical activity, and 327 
probably for the other scavenging properties, specifically involves this kind of electron rich 328 
structures. Finally, the positive correlation observed between the antioxidant response, measured by 329 
the different methods used and the concentration of the OR, provides a strong demonstration of its 330 
antioxidant activity. 331 
In the light of these findings, we thought a) to characterize the low MW components present in the 332 
resinous fraction, and b) to evaluate the  anti-inflammatory activity of OR-PF using a cell system 333 
model of inflammation; c) to evaluate its anti-psoriatic activity. 334 
 335 
3.4 GC-MS profile of the EO and of the resinous fraction from  C. langsdorffii Desf. OR 336 
As evidenced in Fig. 2 and Tables 2 and 3, copaiba contains (a) volatile compounds (essential oil) 337 
and (b) several classes of compounds which become volatiles after derivatization. All the 338 
compounds were identified and characterized by GC-MS: the essential oil was constituted by a set 339 
of forty terpenes and paraffins, constituted by sesquiterpenes (96.36 %), the main of which were -340 
trans-bergamotene (48.38%), -himachalene (11.17%), -caryophyllene (5.47%), -elemene 341 
(5.06%), cyclosativene (5.02%), and -selinene (5.00%), paraffins (2.21%), sesquiterpenols 342 
(0.85%), and diterpenes methyl esthers (0.47%). 343 
Among the nonvolatiles compounds present in the resinous fraction (after derivatization) we found 344 
some interesting labdanic structures, diterpenoic acids, and diterpenes bearings - conjugated 345 
dienes, to the best of our knowledge never identified in the C. langsdorffii Desf. OR before 2012 346 
(Leandro et al., 2012; do Nascimento et al., 2012), i.e. copalic, pimaric, isopimaric, abietic, 347 
daniellic, lambertinic, giberellic acids and a group of labdenoic acid (see Table 3).  348 
In particular, the GC-MS analysis of this last fraction evidenced the presence of a 44.73% of 349 
diterpenic and labdenoic acids, 31.74% of sesquiterpenes, 1.21% of phytormones and pheromones, 350 
3.85% of fatty acids, and 5.58% of diterpenes, among which the 35.68% were unsaturated 351 
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conjugated structures, confirming the results obtained by the UV experiments with H2O2 (see 352 
above). 353 
Among, the bulk of diterpene acids found by us in C. langsdorffii Desf. OR, only kauran-19-oic 354 
acid has been unequivocally characterized by Costa-Lotufo (Costa-Lotufo et al., 2002). In our 355 
samples, kaurenoic acid is present in a very small percentage (approximately 1%), less than the 356 
value reported by the same author. Conversely, in C. langsdorffii Desf. OR, we have found an array 357 
of structurally different diterpene acids, some of which reported in the OR from other Copaifera 358 
species, i.e. pimaric acid, and palustric acid (Imaizumi et al., 2002; Velikova et al., 2000). 359 
 360 
Since we have no doubt on the botanical characterization of Copaifera langsdorffii Desf., and on 361 
the reliability of physical and chemical characterization performed by us (refractive index, optical 362 
rotation), we believe that the great variability of these active structures may stem from a plant 363 
metabolic process of  interconversion of these intermediates along the time. Hence, these 364 
compounds can be considered as metabolic intermediates of the plant metabolism which leads to the 365 
biosynthesis of giberellins (Graebe, 1987).  366 
To gain an insight into the role of this diterpenoic acids into the anti-inflammatory activity of C. 367 
langsdorffii Desf. OR, we investigated this effect using a purified fraction (PF) of the resinous 368 
complex free of the xiloglucanic fraction and containing only the bulk of diterpene acids, diterpenes 369 
and sesquiterpenes. To evaluate its inhibitory effect on IL-1IL-6 and TNF- cytokines secretion, 370 
and on the nuclear translocation of NF-B, we used a model of human THP-1 monocytes, a well-371 
known and largely used model of macrophages precursor (Chanput et al., 2010; Essafi-Benkhadir et 372 
al., 2012). 373 
 374 
3.5 Effects of Copaiba on cytokine secretion by human THP-1 monocytes 375 
A 24-h exposure of THP-1 cells to 1 μg/mL LPS induced the maximal secretion of IL-1β (50-fold, 376 
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p<0.001 vs control; Fig. 3a), IL-6 (44-fold, p<0.001 vs control; Fig. 3b) and TNF-400-fold, 377 
p<0.001 vs control; Fig. 3c), which are released in small amounts in basal conditions. Preincubation 378 
(1 h) with 4x10
-5
 M AA, used as positive control of OR-PF, reduced LPS-stimulated IL-1β, IL-6 379 
and TNF- secretion respectively by 34% (p<0.05), by 22% (p<0.05), and non-significantly by 380 
18%, vs. LPS-stimulated cells (Fig. 3a-c). After 1-h incubation, OR-PF significantly reduced the 381 
secretion of IL-1β (by 44-36%; dose range 0.1 – 10 μM, all p<0.05; Fig. 3a), IL-6 (by 28% and 382 
37%, at the doses of 0.1 and 1 μM; all p<0.05, Fig. 3b) and TNF-by 37% and 31% a the doses of 383 
0.1 and 1 μM respectively; both p<0.05). Interestingly, there was no inhibition of cytokine secretion 384 
when the cells were exposed to the highest concentration of OR-PF (100 μM). None of the OR-PF 385 
concentrations had any effect on the unstimulated secretion of IL-1β, IL-6 and TNF-, nor elicited 386 
any sign of cell toxicity, as indicated by the Trypan blue exclusion test (data not shown). 387 
 388 
3.5.1 Effects of OR-PF on NF-B nuclear translocation in human THP-1 monocytes  389 
We then examined the effect of OR-PF in counteracting LPS-induced nuclear translocation of NF-390 
B in THP-1 cells. WB analysis of cytoplasmic and nuclear extracts showed that LPS alone 391 
promoted translocation of the 52-kDa NF-B subunit of the IB/NF-B complex from the cytosol 392 
to the nucleus, as expected, and 1 μM OR-PF reduced the amount of this protein in the nucleus. The 393 
efficiency of the separation of the nuclear and cytoplasmic fractions was confirmed by the detection 394 
of histone 3 and tubulin, specific markers for the nucleus and the cytoplasm (Fig. 4). 395 
For what concern the mechanism of inhibition of cytokines secretion, we believe that the most 396 
likely candidates moieties are the group of - unsaturated diterpene acids. If this is true, we can 397 
speculate that due to their highly lipophilic character they are able to permeate the THP-1 cells 398 
membrane and establish a covalent binding to the specific target(s) within the cells with the 399 
electrophilic groups of the - unsaturated moieties. 400 
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3. 6 Anti-psoriatic activity: oral administration 401 
After four weeks of treatment, only a slight decrease of scaling and infiltration, compared to the 402 
basal condition, was observed on the legs of the patient 1. For patient 2 lesions on the extensor 403 
surfaces of the elbows appeared not significantly improved (data not shown). After six weeks, the 404 
45-years-old man (patient 1) showed a further decrease of the scaliness of the legs lesions and of the 405 
skin infiltration, as well as an initial attenuation of the erythema redness (Fig. 5A-B). Also for the 406 
36-years-old woman (patient 2) there was an appreciable attenuation of redness of the target 407 
plaques, and a more prominent skin scaling decrease (Fig. 6A-C). 408 
At the end of this period both patients asked to continue the OR oral assumption, and for this reason 409 
the treatment was extended to three months (keeping 1 mL/die as dose). After this additional time 410 
period a fairly complete remission, with almost disappearance of the lesions, was observed (95% 411 
PASI score reduction) for both the subjects and in the follow up period, the therapeutic response 412 
was maintained (one year, data not shown). No allergic reactions or dermatitis were observed. In 413 
addition, blood parameters and liver- and renal- function tests remained in the normal range, further 414 
confirming the safety of C. langsdorffii Desf. OR. 415 
 416 
3.6.1 Topical treatment 417 
At baseline, the extension of the lesions on the right elbow of patient 3 (36 year-old-man) appeared 418 
not larger than that present on the left elbow, but erythema was evident, and as well as the scaling, 419 
and the infiltration nearly severe for both of them. At 2 weeks, no significant improvement was  420 
assessed; at 4 weeks, erythema appeared only a little bit improved, not yet to decrease from 3 to 2 421 
of the PASI scale, but both infiltration and scaling achieved a point degree of improvement, from 422 
severe to moderate. At 6 weeks, erythema improved by two points, from moderate to mild; the 423 
scaling and infiltration follow the same trend from moderate to mild (Fig. 7). Tolerability for C. 424 
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langsdorffii Desf. OR ointment was declared to be very good by the patient.  425 
The results of these pilot and preliminary oral and topical treatments demonstrate the efficacy of the 426 
OR from C. langsdorffii Desf., in ameliorating the typical clinical signs of psoriasis. 427 
 428 
4. Conclusions 429 
In conclusion, the results of this study demonstrate for the first time that the oleoresin (OR) from C. 430 
langsdorffii Desf. possesses different well established biological properties, which range from a 431 
strong antioxidant capacity to an anti-inflammatory activity and to a potential anti-psoriatic effect.  432 
These properties are not due to the presence of phenolic/polyphenolic species but to several volatile 433 
sesquiterpenes, and to the concomitant presence of unsaturated diterpene acids components (of 434 
which copalic acid is the most abundant in C. langsdorffii Desf. OR, followed by abietic acid, 435 
polialtic acid, kaurenoic acid etc.) and of diterpene and sesquiterpene species, all embedded within 436 
the polymeric xiloglucan matrix.  437 
We also have demonstrated that these components exert a significant anti-inflammatory action 438 
based on the inhibition of cytokine secretion, consequent to an interaction with the NF-B 439 
signalling pathway, thus explaining the health benefits deriving from the topical or oral 440 
administration in vivo of the oleoresin. 441 
In this context, the significant clinical improvement, without any apparent systemic adverse effect, 442 
observed in psoriatic patients recalcitrant to conventional pharmacological therapy (corticosteroids 443 
and vitamin D analogues), is a clear indication of the anti-inflammatory and potentially anti-444 
proliferative action of the same.  445 
These results open the way to further in depth pharmaceutical studies on the use of this potent 446 
natural phytocomplex in the treatment of inflammatory diseases, as well as to investigations aimed 447 
to maximize its bioavailability and improve its delivery to the target sites (inclusion in 448 
cyclodextrins, microencapsulation, etc.) and its safety after topical and/or systemic administration.  449 
Page 21 of 37
Ac
ce
pte
d M
an
us
cri
pt
20 
Acknowledgements  450 
Authors gratefully acknowledge the Interuniversitary Consortium TEFARCO Innova for the 451 
research support. This research was financially supported by MIUR (Rome) as a Project within 452 
PRIN2007 and PRIN2009. The authors thanks also Dr Angelo Naj Oleari of Centro Botanico/ 453 
Prodotti Naturali S.p.A., (Milan, Italy) for providing the C. Langsdorffii Desf. OR. 454 
Page 22 of 37
Ac
ce
pte
d M
an
us
cri
pt
21 
References 455 
 456 
Beers Jr, R.F., Sizer, I.W., 1952. A spectrophotometric method for measuring the breakdown of 457 
hydrogen peroxide by catalase. J. Biol. Chem. 195, 133-40. 458 
Beretta, G., Artali, R., Maffei Facino, R., Gelmini, F., 2011. An analytical and theoretical approach 459 
for the profiling of the antioxidant activity of essential oils: The case of Rosmarinus officinalis L. J. 460 
Pharm. Biomed. Anal. 55, 1255–1264. 461 
Carvalho, J.C.T., Cascon, V.,  Possebon, L.S.,  Morimoto, M.S.S.,  Cardoso, L.G.V.  Kaplan, 462 
M.A.C.,  Gilbert, B., 2005. Topical antiinflammatory and analgesic activities of Copaifera duckei 463 
dwyer. Phytother. Res. 19, 946–950. 464 
Cascon, V., Gilbert, B., 2000. Characterization of the chemical composition of ORs of Copaifera 465 
guianensis Desf., Copaifera duckei Dwyer and Copaifera multijuga Hayne. Phytochemistry. 55, 466 
773–778. 467 
Chanput, W., Mes, J., Vreeburg, R.A.M., Savelkoul, H.F.J., Wichers, H.J., 2010. Transcription 468 
profiles of LPS-stimulated THP-1 monocytes and macrophages: a tool to study inflammation 469 
modulating effects of food-derived compounds. Food Funct. 1, 254-261. 470 
Corsini, E., Sangiovanni, E., Avogadro, A., Galbiati, V., Viviani, B., Marinovich, M., Galli, C.L., 471 
Dell'Agli M., Germolec, D.R., 2011. In vitro characterization of the immunotoxic potential of 472 
several perfluorinated compounds (PFCs). Toxicol. Appl. Pharmacol. 258, 248-255.  473 
Costa-Lotufo, L.V., Cunha, G.M., Farias, P.A., Viana, G.S., Cunha, K.M., Pessoa, C., Moraes, 474 
M.O., Silveira, E.R., Gramosa, N.V., Rao, V.S., 2002. The cytotoxic and embryotoxic effects of 475 
kaurenoic acid, a diterpene isolated from Copaifera langsdorffii oleo-resin. Toxicon. 40, 1231-1234. 476 
Do Nascimento, M.E., Zoghbi, M.D.G.B., Brasil Pereira Pinto, J.E., Vilela Bertolucci, S.K., 2012. 477 
Chemical variability of the volatiles of Copaifera langsdorffii growing wild in the Southeastern part 478 
of Brazil, Biochem. Syst. Ecol. 43, 1-6. 479 
Page 23 of 37
Ac
ce
pte
d M
an
us
cri
pt
22 
DuBois, M.,  Gilles, K.A.,  Hamilton, J.K., Rebers, P.A., Smith, F., 1956. Colorimetric Method for 480 
Determination of Sugars and Related Substances. Anal. Chem. 28, 350–356. 481 
Essafi-Benkhadir, K., Refai, A., Riahi, I., Fattouch, S., Karoui, H., Essafi, M., 2012. Quince 482 
(Cydonia oblonga Miller) peel polyphenols modulate LPS-induced inflammation in human THP-1-483 
derived macrophages through NF-κB, p38MAPK and Akt inhibition. Biochem. Biophys. Res. 484 
Commun. 418, 180-185. 485 
Feldman, S., Krueger, G., 2005. Psoriasis assessment tools in clinical trials. Ann. Rheum. Dis. 64, 486 
ii65–ii68. 487 
Fox, J., 2005. The R-commander. A basic statistics graphical user interface to R. J. Stat. Softw. 14, 488 
1–42. 489 
Graebe, J.E., 1987. Gibberellin Biosynthesis and Control. Annu. Rev.  Plant Physiol. 38, 419-465. 490 
Halliwell, B.,  Gutteridge, J.M.C., Aruoma, O.I., 1987. The deoxyribose method: A simple “test-491 
tube” assay for determination of rate constants for reactions of hydroxyl radicals. Anal. Biochem. 492 
165, 215–219. 493 
Leandro, L.M., De Sousa Vargas, F., Barbosa, P.C.S., Neves, J.K.O., Da Silva, J.A., Da Veiga-494 
Junior, V.F. 2012. Chemistry and biological activities of terpenoids from copaiba (Copaifera spp.) 495 
oleoresins. Molecules 17, 3866-3889. 496 
Magni, P., Ruscica, M., Dozio, E., Rizzi, E., Beretta, G., Facino, R.M., 2012. Parthenolide Inhibits 497 
the LPS-induced Secretion of IL-6 and TNF-α and NF-κB Nuclear Translocation in BV-2 498 
Microglia. Phytother. Res. doi: 10.1002/ptr.3732. 499 
Price, M.L.,  Butler, L.G., 1977. Rapid visual estimation and spectrophotometric determination of 500 
tannin content of sorghum grain. J. Agric. Food Chem. 25, 1268–1273. 501 
Santos, A.O., Ueda-Nakamura, T., Dias Filho, B.P., Veiga, V.F.,  Pinto, A.C.,  Nakamura, C.V., 502 
2008. Effect of Brazilian copaiba oils on Leishmania amazonensis. J. Ethnopharmacol. 120, 204–503 
208. 504 
Page 24 of 37
Ac
ce
pte
d M
an
us
cri
pt
23 
Silva Tiné, M.A., de Lima, D.U., Buckeridge, M.S., 2003. Galactose branching modulates the 505 
action of cellulase on seed storage xyloglucans. Carbohydrate Polymers. 52, 135–141. 506 
Stupp, T.,  de Freitas, R.A.,  Sierakowski, M.R.,  Deschamps, F.C.,  Wisniewski Jr., A., Biavatti, 507 
M.W., 2008. Characterization and potential uses of Copaifera langsdorfii seeds and seed oil. 508 
Bioresour. Technol. 99, 2659–2663.  509 
Van der Geer, J., Hanraads, J.A.J., Lupton, R.A., 2010. The art of writing a scientific article. J. Sci. 510 
Commun. 163, 51–59.  511 
Vinson, J.A., Proch, J., Bose, P., 2001. Determination of quantity and quality of polyphenol 512 
antioxidants in foods and beverages. Methods Enzymol. 335,  103-114. 513 
Veiga Jr, V.F., Zunino, L.,
 
Calixto, J.B., Patitucci, M.L., Pinto, A.C., 2001. Phytochemical and 514 
antioedematogenic studies of commercial copaiba oils available in Brazil. Phytother. Res. 15,  476–515 
480. 516 
Velikova, M., Bankova, V., Tsvetkovab, I., Kujumgiev, A., Marcuccic, M.C., 2000. Antibacterial 517 
ent-kaurene from Brazilian propolis of native stingless bees. Fitoterapia. 71, 693-696. 518 
Yen, G.C., Duh, P.D., 1994. Scavenging Effect of Methanolic Extracts of Peanut Hulls on Free-519 
Radical and Active-Oxygen Species. J. Agric. Food Chem. 42, 629–632. 520 
Imaizumi, Y., Sakamoto, K., Yamada, A., Hotta, A., Ohya, S., Muraki, K., Uchiyama, M., Ohwada, 521 
T., 2002. Molecular Basis of Pimarane Compounds as Novel Activators of Large-Conductance 522 
Ca
2+
-Activated K
+
 Channel α-Subunit. Mol. Pharmacol. 62, 836-846. 523 
 524 
 525 
 526 
 527 
 528 
 529 
Page 25 of 37
Ac
ce
pte
d M
an
us
cri
pt
24 
Figure Captions 530 
 531 
Fig.1. Conjugated dienes disappearance ( 272) in OR from C. langsdorffii Desf. induced by the 532 
addition of 2 mM H2O2. 533 
 534 
Fig. 2. GC-MS profile of: (A) EO and (B) OR-PF isolated in OR from C. langsdorffii Desf. Peaks 535 
identification is reported in Tables 2 and 3. 536 
 537 
Fig. 3. Effect of C. langsdorffii Desf. OR-PF (Oleoresin-Purified Fraction) on IL-1β, IL-6 and TNF-538 
α secretion in cultured THP-1 monocytes. Cells were pretreated or not for 1 h with different OR-PF 539 
concentrations (ranging from 0.1 to 100 M) and then exposed (or not) to 1 μg/mL LPS for another 540 
24 h with the same OR-PF concentrations. Abietic acid (AA, 5x10
-4
 M) was used as positive OR-PF 541 
control. Data are expressed as mean ± SEM, n = 3; °p<0.001 vs control, *p<0.05 vs LPS (ANOVA). 542 
 543 
Fig. 4. Effect of OR-PF on the nuclear translocation of NF-κB in cultured THP-1 monocytes. The 544 
cells, pretreated or not, for 1 h with 1 M OR-PF, were stimulated (or not) for 30 min with 1 g/mL 545 
LPS, again with or without 1 M OR-PF. The subcellular localization of the NF-κB p65 subunit (52 546 
kDa) was examined by Western blotting analysis. The quality of the separation of the nuclear and 547 
cytoplasmic fractions was confirmed by detection of the respective specific proteins, histone 3 (17 548 
kDa) and tubulin (50 kDa). (C): control (RPMI). 549 
 550 
Fig. 5. Patient 1, legs of a 45 -years-old man with an 8-year history of recalcitrant chronic psoriasis. 551 
(A) baseline and (B) after 6 weeks of oral intake of OR from C. langsdorffii Desf. 552 
 553 
Fig. 6. Patient 2, right elbow of a 36-years-old woman with an 8-year history of recalcitrant chronic 554 
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psoriasis. (A) at the baseline; (B) after 4 weeks of oral intake of OR from C. langsdorffii Desf.; (C) 555 
after 6 weeks of oral intake of OR from C. langsdorffii Desf.. 556 
 557 
Fig. 7. Patient 3, elbows of a 36-years-old man with an 8-year history of recalcitrant chronic 558 
psoriasis. (A) right elbow at the baseline; (B) right elbow after 6 weeks of calcipotriol topical 559 
treatment; (C) left elbow at the baseline; (D) left elbow after 6 weeks of topical treatment with OR 560 
from C. langsdorffii Desf. 561 
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Table 1 
Physical descriptors of the C. langsdorffii Desf. OR. 
Descriptors Experimental evaluation U.S. Dispensatory Reference 
Color OR pale yellow clear oily colorless or pale yellow 
Odor OR sweet, linalolic odor, woody odor and taste of Copaiba 
Boiling point 255.00 ± 0.01 252.00-256.00 °C 
Specific gravity OR (g/mL) 0.902 ± 0.001 0.896 to 0.910 
Refractive index EO(t= 25 °C) 1.4967 ± 0.004 1.4940 to 1.5000 
Optical rotation OR [α]20/D - 12 ° -7° to -35° 
  
Table(s)
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Table 2 
GC-MS analysis of C. langsdorffii Desf. essential oil: peak identification, and area percentage. 
Compounds R.T. 
(min) 
% Compounds R.T. 
(min) 
% 
3-octene, (Z)- 3.050 0.32 isolongifolene, 4,5-dehydro 20.312 0.13 
3-octene, (E)- 3.168 1.05 -guaiene 20.397 0.24 
unidentified paraffin 3.259 0.15 cuparene 20.667 0.48 
4-octene, (Z)- 3.296 0.68 isocaryophyllene 20.842 1.63 
(+)-cyclosativene 16.365 5.02 -selinene 21.145 5.01 
-copaene 16.560 0.57 -selinene 21.422 2.57 
-gurjunene 16.753 0.14 -himachalene 21.901 11.17 
-farnesene 16.879 0.58 isolongifolene, 4,5,9,10-dehydro- 22.532 0.21 
-elemene 17.027 5.06 -chamigrene 22.987 0.14 
di-epi--cedrene 17.426 0.16 caryophyllene oxide 23.264 0.52 
-selinene 17.664 1.42 diepicedrene-1-oxide 24.915 0.17 
-longipinene 17.906 1.22 aromadendrene oxide-(2) 25.254 1.09 
-santalene 18.151 0.27 -elemene 25.848 0.39 
-caryophyllene 18.270 5.47 longipinocarveol, trans- 26.555 0.14 
-bergamotene 18.771 48.38 ledene oxide-(II) 27.841 0.12 
cedrene 18.976 0.37 -himachalene 28.267 0.13 
bergamotol, Z--trans- 19.111 0.60 unidentified sesquiterpene 28.721 0.20 
epi--santalene 19.277 0.76 (-)-spathulenol 29.449 0.11 
-farnesene 19.386 1.01 dehydroabietic acid methyl ester 59.429 0.13 
-humulene 19.704 1.67 abietic acid, methyl ester 61.398 0.34 
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Table 3 
GC-MS analysis of C. langsdorffii  Desf. OR-PF: peak identification, and area percentage 
Compounds R.T. (min) % Compounds R.T. (min) % 
1-hexene, 4-methyl- 3.196 0.29 -humulene 29.572 0.79 
heptane, 2,4-dimethyl- 3.602 5.03 sclaral 30.729 4.58 
-clavene 16.662 0.39 androst-5-en-4-one, 40.977 0.67 
-selinene 17.427 0.30 androstan-17-one, 3-ethyl-3-hydroxy-,(5a)- 41.177 0.15 
longifolene-(V4) 17.649 0.44 gibberellic acid 41.468 0.40 
alloaromadendrene 17.834 0.26 isopimaric acid 41.734 1.48 
caryophyleine-(I3) 18.096 1.08 pentadecanoic acid, 13-methyl- 41.777 1.51 
n.i. sesquiterpene 19.349 0.79 pimarinal 43.313 0.20 
cyperene 19.616 0.93 abietic acid 43.744 0.58 
-guajene 20.110 1.07 13-Isopimaradiene 44.562 0.21 
-selinene 20.365 2.14 kaur-16-ene 44.677 1.57 
-muurulene 20.478 1.97 sclarene 45.880 0.54 
cuparene 20.622 1.04 biformene 46.566 0.39 
cadinene 20.947 2.65 ent kaur-16-ene 46.833 0.46 
-selinene 21.350 1.72 cembrene 47.370 0.16 
elixene 21.454 1.24 8,11-Octadecadienoic acid 49.382 1.54 
germacrene B 21.901 3.38 elaidic acid 49.727 0.55 
-himachalene 22.631 0.88 sclareol 50.685 0.46 
-gurjunene 22.943 0.67 labd-7-en-15-oic acid 54.757 7.15 
-chamigrene 23.232 2.31 n.i. labdane 55.328 0.25 
cubenol 24.148 0.46 labd-7-en-15-oic acid 55.995 0.47 
n.i. sesquiterpenol 25.723 2.32 copalic acid isomer A 58.249 0.81 
(-)-caryophyllene-(I1) 26.152 0.71 copalic acid 59.441 22.15 
isoaromadendrene epoxide 26.297 0.31 valencene 60.111 3.36 
-eudesmene 27.026 0.65 pimaric acid 60.531 1.80 
eudesma-4(14),11-diene 27.975 1.53 daniellic acid 61.313 5.38  
-eudesmol 28.645 0.21 lambertinic acid 62.496 2.15 
calarene epoxide 28.952 0.57 kauran-19-oic acid 63.348 1.08 
n.i. sesquiterpene 29.346 2.14 labd-8(20)-ene-15,18-dioic acid, dimethyl ester 65.802 1.67 
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Figure 5 
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Figure 6 
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Figure 7 
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Scheme 1 
 
Copaiba 
oleoresin vacuum evaporation 
(100°C 
steam distillation 
Resinous 
fraction 
Essential oil 
Human studies 
(Psoriasis Area and Severity index) 
MeOH/OH (6N) 
Extraction with n-Hexane 
to dryness 
HClconc (37%) 
2 min under reflux 
Extraction with n-Hexane, to dryness 
OR-PF 
Diterpene acids 
Diterpenes 
Sesquiterpenes 
Fatty acids 
Paraffins 
In vitro cell culture 
studies 
(cytokines secretion) 
Esterified diterpene acids 
Diterpenes 
Sesquiterpenes 
Esterified fatty acids 
Paraffins 
 
GC-MS 
analysis 
